Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
AB Sciex

HbA1c and Diabetic Ketoacidosis POC Analyzers to Be Demonstrated at ArabHealth

By Labmedica International staff writers
Posted on 03 Jan 2014
Image: The EKF Quo-Lab HbA1c Analyzer (Photo courtesy of EKF Diagnostics).
Image: The EKF Quo-Lab HbA1c Analyzer (Photo courtesy of EKF Diagnostics).
A leader in in-vitro diagnostics will exhibit in an upcoming medical congress two point-of-care (POC) analyzers for the rapid assessment of diabetes and related conditions.

The Quo-Lab HbA1c analyzer and the STAT-Site M β-HB by EKF Diagnostics (EKF; Cardiff, UK) will be demonstrated at the Welsh stand during the ArabHealth healthcare exhibition and medical congress, which will take place January 27–30, 2014, at the International Convention and Exhibition Center in Dubai (UAE).

HbA1c monitoring is increasingly used in the detection and management of diabetes: Quo-Lab provides highly accurate, affordable, and easy-to-use technology, which uses only 4 µL of venous or finger prick blood to deliver results within four minutes. The analyzer, which was launched mid-2013, has had a good reception, with nearly 1,300 being sold globally to date. The Quo-Lab analyzer is designed to meet the needs of GP surgeries, clinics, and laboratories in emerging economies, where diabetes has become a growing public health issue.

The second analyzer to be demonstrated, the STAT-Site M β-HB, is a quantitative strip-based test for ß-Hydroxybutyrate (ß-HB). The device provides quick and easy assessment of diabetic ketoacidosis (DKA), delivers results in less than 80 seconds, and it is CE marked.

Using the STAT-Site M ß-HB, the presence and degree of ketosis can be assessed at POC by accurately measuring blood levels of ß-HB, which accounts for 78% of the three ketone bodies, from just 10 µL of serum or plasma. This provides useful information to deliver quality care when monitoring DKA in newly diagnosed patients, while also reducing time and costs in an emergency room setting.

Related Links:

EKF Diagnostics



GREINER-BIO-ONE
PURITAN MEDICAL
ADVANCED INSTRUMENTS
BioConferenceLive

Channels

Genetic Tests

view channel
Image: The QuantiTect Reverse Transcription Kit (Photo courtesy of Qiagen)

Blood Tests Predict Risk of Sudden Cardiac Death

A simple blood test can predict a person's risk for sudden cardiac death, enabling physicians to quickly and accurately assess a patient's need for an implantable cardiac defibrillator (ICD).... Read more

Hematology

view channel

Blood Donations Screened for Viruses Using Multiplex Assay

A global healthcare company was chosen to partner the Japanese Red Cross (JRC; Tokyo, Japan) for nucleic acid screening of the nation's blood supply. Under the terms of the 7-year agreement, the healthcare company, Grifols (Barcelona, Spain) will provide the JRC with its newest automation platform, the Procleix Panther... Read more

Pathology

view channel

Gene Profile Predicts Risk of Bladder Cancer Recurrence

A genomic study has pinpointed several markers that identify bladder cancer patients at risk of recurrence and that may be indicators of overall survival status. Nearly half of patients with bladder cancer experience recurrences, so reliable predictors of this recurrent phenotype are needed to guide surveillance and treatment.... Read more

Industry News

view channel

Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System

The diagnostics division of Beckman Coulter (Brea, CA, USA) and hc1.com (Indianapolis, IN, USA) have announced a partnership to bring an innovative healthcare cloud-technology system to clinical laboratories. The system, hc1.com's "Healthcare Relationship Cloud," helps turn large amounts of clinical data into actionable... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.